Interleukin-6 as a key player in systemic inflammation and joint destruction.
about
Erythropoiesis-stimulating agents for anemia in rheumatoid arthritisErythropoiesis-stimulating agents for anemia in rheumatoid arthritisOsteoimmunology and the influence of pro-inflammatory cytokines on osteoclastsSpotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to dateIL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophiliaThe mechanisms of up-regulation of dendritic cell activity by oxidative stressThe synovio-entheseal complex in enthesoarthritis.The clinical application value of cytokines in treating infectious diseases.Inhibitory effect of Jeju endemic seaweeds on the production of pro-inflammatory mediators in mouse macrophage cell line RAW 264.7.Biological treatments in Behçet's disease: beyond anti-TNF therapy.The roles of catabolic factors in the development of osteoarthritis.Rose hip and its constituent galactolipids confer cartilage protection by modulating cytokine, and chemokine expression.Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis.Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550).Genome-wide DNA methylation profiling in rheumatoid arthritis identifies disease-associated methylation changes that are distinct to individual T- and B-lymphocyte populations.JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy.The development and future of reconstructive and microvascular surgery of the hand.Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytClinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.Muscular and systemic correlates of resistance training-induced muscle hypertrophy.A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis.Both 25-hydroxyvitamin-D3 and 1,25-dihydroxyvitamin-D3 reduces inflammatory response in human periodontal ligament cellsTranscription factor Hes1 modulates osteoarthritis development in cooperation with calcium/calmodulin-dependent protein kinase 2.A multi-nutrient supplement reduced markers of inflammation and improved physical performance in active individuals of middle to older age: a randomized, double-blind, placebo-controlled study.Characterization of a novel and spontaneous mouse model of inflammatory arthritis.Clcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis.The future of rheumatoid arthritis and hand surgery - combining evolutionary pharmacology and surgical techniqueIs Still's Disease an Autoinflammatory Syndrome?Oral inflammatory diseases and systemic inflammation: role of the macrophage.Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid ArthritisIntragingival injection of Porphyromonas gingivalis-derived lipopolysaccharide induces a transient increase in gingival tumour necrosis factor-α, but not interleukin-6, in anaesthetised rats.A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease.Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to P. gingivalis Lipopolysaccharide.Outer membrane vesicles of Tannerella forsythia: biogenesis, composition, and virulenceInterleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditionsCytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators?Role of odanacatib in reducing bone loss due to endodontic disease: An overview.Interleukin-6-dependent influence of nociceptive sensory neurons on antigen-induced arthritis.Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation.The effects of adipokines on cartilage and meniscus catabolism
P2860
Q24200775-A79B73A3-F490-42E9-AB84-B373C26342C8Q24234260-C94E8264-4574-4F08-A657-F57191D5BF37Q26828486-70635AB3-B5E9-4B2D-AC96-EC016F9F7F94Q28076558-9D980672-80EF-46E6-8432-327C7F2C8ECEQ30439206-FC78F354-E513-405D-9C4C-D1888789238BQ30583882-44C3B279-B9D3-40A6-9223-C166A807F626Q33360030-3C5F0D9A-8AE4-4D00-9C6C-939206D7D118Q33700537-B0A6BEF9-1A3D-4967-90F5-A5F51FD666AFQ33834601-F3C16B51-0FA5-45C1-ACBC-9EB9F446FA04Q33908217-2B2DC16C-2B42-4807-80EB-F7515C66F3BDQ34009214-BDB427D0-217A-43B2-9EB6-1DECC666B101Q34066453-2D2CABA3-B8D8-46BB-9D84-BCC703BAE2AEQ34152981-68AA5520-3D81-4CEE-BD72-F85F9E99D81EQ34169114-D7C4C0C7-EE40-49DA-93DA-E68A3839B724Q34212663-88EF406A-77FD-4AFC-994C-58A6B779F0A6Q34276089-E0A4A903-5BC4-42DF-8E5D-FEE0077A39DDQ34529734-ACCF1206-85F2-4E44-B981-6C23138357DEQ34802374-9D7FB51A-4E07-4402-8A00-75B51BB2252BQ35003674-248D8BAF-78BA-44A5-8DA0-31CE251114E3Q35018938-3D9A37B2-1035-45BB-A5DC-26B50C638AEFQ35093044-433E0924-43EE-471D-965E-CB3E35702D99Q35108940-C637935B-AC54-4E78-802F-1144EDC3914AQ35190041-37712BD9-9D56-4862-9A63-838FA5539506Q35232961-BD0C28BC-4B7B-4042-990C-34F2883748C3Q35617627-1FC5A40F-6BEB-46C3-90EB-F4AA04794F08Q35702593-9948F340-694C-4B14-8436-35D6E743D186Q35810276-BDC99DA4-55CD-4762-B9B0-7045BD55E56FQ35955190-77B02907-5187-46EA-B298-9C0324FA88E0Q35963446-87131F57-50C6-47C9-9260-C094E4969E30Q36088239-C4BB953B-4B55-4EEE-9D7B-1DE8288D088FQ36091804-CD66A4B0-13E5-496F-9D24-E894EEAF73CFQ36094049-EB330291-1C88-4F54-A57B-0914A11F468AQ36098513-79EC7BDC-C6A3-48ED-9668-74B108993075Q36159350-320566CB-0D18-4B38-8DFA-2B5CEF552C91Q36161896-071966D8-6629-44C4-94B8-0B18E4E4261AQ36245722-5293C614-328F-4F43-90BB-44876532222CQ36285195-967AE0B2-4BEC-43EB-9831-24B02CF492C6Q36304006-AEB94ADD-57B1-4DC1-A86F-CD425B3EB79EQ36472866-3D77FDCA-884F-4FF4-B7C0-2C131E3C8AAAQ36741296-1915D1C1-CFB7-49FF-A1AB-E7FCA367E41C
P2860
Interleukin-6 as a key player in systemic inflammation and joint destruction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interleukin-6 as a key player in systemic inflammation and joint destruction.
@en
Interleukin-6 as a key player in systemic inflammation and joint destruction.
@nl
type
label
Interleukin-6 as a key player in systemic inflammation and joint destruction.
@en
Interleukin-6 as a key player in systemic inflammation and joint destruction.
@nl
prefLabel
Interleukin-6 as a key player in systemic inflammation and joint destruction.
@en
Interleukin-6 as a key player in systemic inflammation and joint destruction.
@nl
P50
P1433
P1476
Interleukin-6 as a key player in systemic inflammation and joint destruction
@en
P2093
P304
P356
10.1016/J.AUTREV.2009.01.012
P577
2009-02-02T00:00:00Z